Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Breast cancer trends in 2021 and beyond

Komal Jhaveri, MD, FACP, Memorial Sloan Kettering Cancer Center, New York, NY, discusses future endeavors in the treatment of breast cancer, including triplet combination targeted therapies such as those evaluated in the SUMMIT trial (NCT01953926), as well as recent approvals of novel antibody-drug conjugates such as sacituzumab govitecan. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).